Literature DB >> 16933120

[The significance of inguinal lymphadenectomy in carcinoma of the penis].

E Preis1, G Jakse.   

Abstract

The occurrence of inguinal lymph node metastases from squamous cell carcinoma of the penis depends on local tumor extension, tumor grade, and vascular invasion. Whilst imaging techniques and fine needle biopsy can detect metastases to the inguinal nodes, resection of the superficial inguinal nodes remains the procedure of choice for diagnosis. The risk profile defined in the guidelines of the EAU is used to decide whether modified inguinal lymphadenectomy is indicated in the case of nonpalpable lymph nodes. Resection of the sentinel lymph node marked by (99)Tc and dye has not yet been adequately evaluated as an alternative to be accepted as the standard method.When the superficial inguinal lymph nodes are found to harbor metastases the next step is a radical bilateral inguinal lymphadenectomy. When metastases are found in two lymph nodes or extranodal tumor growth is observed, or imaging techniques reveal enlarged nodes in the pelvis the lymphadenectomy is extended to the pelvic nodes. With appropriate surgical technique and postoperative care the complication rate is low; in particular, persistent lymphedema of the legs is rarely observed. Chemotherapy and radiotherapy and the two combined have not been tested for efficacy, but are used individually before and after surgery, depending on the local tumor extent.

Entities:  

Mesh:

Year:  2006        PMID: 16933120     DOI: 10.1007/s00120-006-1176-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  39 in total

1.  Bilateral ilioinguinal lymph node dissection in the management of cancer of the penis.

Authors:  J E Pow-Sang; V Benavente; J M Pow-Sang; M Pow-Sang
Journal:  Semin Surg Oncol       Date:  1990

2.  Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience.

Authors:  Bin K Kroon; Simon Horenblas; Willem Meinhardt; Henk G van der Poel; Axel Bex; Harm van Tinteren; Renato A Valdés Olmos; Omgo E Nieweg
Journal:  Eur Urol       Date:  2005-01-22       Impact factor: 20.096

3.  Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma.

Authors:  Bin K Kroon; Simon Horenblas; Eline E Deurloo; Omgo E Nieweg; Hendrik J Teertstra
Journal:  BJU Int       Date:  2005-03       Impact factor: 5.588

4.  Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series.

Authors:  Bradford A Nelson; Michael S Cookson; Joseph A Smith; Sam S Chang
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

5.  Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience.

Authors:  C A Pettaway; L L Pisters; C P Dinney; F Jularbal; D A Swanson; A C von Eschenbach; A Ayala
Journal:  J Urol       Date:  1995-12       Impact factor: 7.450

Review 6.  The role of lymphadenectomy in penile cancer.

Authors:  Ricardo F Sánchez-Ortiz; Curtis A Pettaway
Journal:  Urol Oncol       Date:  2004 May-Jun       Impact factor: 3.498

Review 7.  Advanced penile carcinoma.

Authors:  Daniel J Culkin; Tomasz M Beer
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

8.  Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system.

Authors:  S Horenblas; H van Tinteren
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

9.  Treatment of carcinoma of the penis: the case for primary lymphadenectomy.

Authors:  W S McDougal; F K Kirchner; R H Edwards; L T Killion
Journal:  J Urol       Date:  1986-07       Impact factor: 7.450

10.  Penile cancer: relation of extent of nodal metastasis to survival.

Authors:  V Srinivas; M J Morse; H W Herr; P C Sogani; W F Whitmore
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

View more
  1 in total

Review 1.  [Options in palliative therapy for penile cancer].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.